Implanet was granted a U.S. patent protecting the JAZZ® technology platform through 2032.
The patent protects the braided implant and its tensioning system, the principal element of its instrumentation. Implanet now holds intellectual property coverage in its priority markets, including the U.S., Europe, China, Japan, Australia and South Africa.
The company claims to be the only owner, apart from Zimmer Spine, of patents for spinal fixation technology that enables braid tension and implant position on the rod to be locked with a single screw.
Implanet was granted a U.S. patent protecting the JAZZ® technology platform through 2032.
The patent protects the braided implant and its tensioning system, the principal element of its instrumentation. Implanet now holds intellectual property coverage in its priority markets, including the U.S., Europe, China, Japan, Australia and South...
Implanet was granted a U.S. patent protecting the JAZZ® technology platform through 2032.
The patent protects the braided implant and its tensioning system, the principal element of its instrumentation. Implanet now holds intellectual property coverage in its priority markets, including the U.S., Europe, China, Japan, Australia and South Africa.
The company claims to be the only owner, apart from Zimmer Spine, of patents for spinal fixation technology that enables braid tension and implant position on the rod to be locked with a single screw.
Copy to clipboard 
